Current Drug Targets
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 62.6% | 0.726 | Q2 | 74.1% |
| 2024 | 2.5 | Q3 | 49.0% | 0.693 | Q2 | 73.2% |
| 2023 | 3.0 | Q2 | 62.5% | 0.691 | Q2 | 75.3% |
| 2022 | 3.2 | Q3 | 57.0% | 0.621 | Q2 | 73.1% |
| 2021 | 2.9 | Q3 | 49.5% | 0.654 | Q2 | 75.6% |
| 2020 | — | — | 0.826 | Q2 | 80.6% | |
| 2019 | — | — | 0.741 | Q2 | 78.4% | |
| 2018 | — | — | 0.825 | Q2 | 79.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1389-4501
ISSN
1873-5592
country
AEcoverage
2000-2026